Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.

scientific article published on 15 April 2007

Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID17444586

P50authorLoïc GuillevinQ88410079
P2093author name stringEric Hachulla
Luc Mouthon
David Launay
Marc Lambert
Pierre-Yves Hatron
Christian Pagnoux
Martine Remy-Jardin
Sandrine Morell-Dubois
Pascal de Groote
Regis Matran
Viviane Queyrel
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectpulmonary hypertensionQ1128595
P304page(s)1005-1011
P577publication date2007-04-15
P1433published inThe Journal of RheumatologyQ7743623
P1476titlePrevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
P478volume34

Reverse relations

cites work (P2860)
Q35617799Associated pulmonary arterial hypertension in connective tissue diseases
Q38218044Clinical and laboratory profiles of 136 systemic sclerosis patients with and without echocardiographically detected pulmonary hypertension
Q61807910Comprehensive Exercise Capacity and Quality of Life Assessments Predict Mortality in Patients with Pulmonary Arterial Hypertension
Q38071978Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis
Q34430183Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension
Q33649222Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension.
Q33681073Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury
Q35993982Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study
Q50051189Multiparametric Magnetic Resonance Imaging in the Assessment of Pulmonary Hypertension: Initial Experience of a One-Stop Study.
Q33727800Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience
Q36447388Pathogenic mechanisms of pulmonary arterial hypertension
Q89566570Prevalence of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease
Q37133823Provider recognition and response to echocardiographic findings indicating pulmonary hypertension in the Veterans affairs medical center population
Q59303969Pulmonary arterial hypertension
Q37976985Pulmonary hypertension in chronic hypersensitivity pneumonitis
Q38075430Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis
Q35035897Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosis
Q33919119Scleroderma lung disease
Q38135045Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review.
Q35857181Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension
Q36691452Use of echocardiographic pulmonary acceleration time and estimated vascular resistance for the evaluation of possible pulmonary hypertension